Novel peptide formulation shows promise of treating cognitive decline in schizophrenia

Novel peptide formulation shows promise of treating cognitive decline in schizophrenia." ScienceDaily. ScienceDaily, 27 June 2024. <www.sciencedaily.comJapan Advanced Institute of Science and Technology. . Novel peptide formulation shows promise of treating cognitive decline in schizophrenia.

A new study shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The increased risk may be due to alterations in the brain's ... Researchers have discovered a deficiency in the brains of people with schizophrenia that could lead to the development of new drug therapies. A postmortem comparison revealed that schizophrenia was ...

Researchers have shown that microglia, a class of immune cells in the brain, regulate the permeability of the brain's protective barrier in response to systemic inflammation. During inflammation, ... Those with a family history of schizophrenia and men with lower IQ are more likely to struggle with treatment resistant schizophrenia than others with the mental disorder, according to a new study. ...Research on the Visual Rabbit Illusion Takes a Leap Forward

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novel peptide formulation shows promise of restoring cognitive decline in schizophreniaSchizophrenia is a complicated mental health disorder accompanied by a wide range of symptoms such as hallucinations, impaired cognitive ability, and disorganized speech or behavior. It has been associated with anomalies in neurotransmission due to the imbalance of chemical neurotransmitters.
Source: physorg_com - 🏆 388. / 55 Read more »